Blood Transfusion in Trauma and Critical Care ...

High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome. J Trauma 44:361-7 1998 Gabriel A 1 This is a prospective randomized placebo controlled trial. A total of 21 patients were enrolled of which 11 patients received high-dose EPO. Two were ultimately excluded. ................
................